Changes in COVID-19 Vaccine Acceptability among Parents with Children Aged 6–35 Months in China—Repeated Cross-Sectional Surveys in 2020 and 2021
Abstract
:1. Introduction
2. Materials and Methods
2.1. Study Design
2.2. Participants and Data Collection
2.3. Measures
2.3.1. Design of the Questionnaire
2.3.2. Background Characteristics
2.3.3. COVID-19 Vaccine Acceptability for Their Children
2.3.4. Individual Level Factors: Parental Hesitancy to Receive a COVID-19 Vaccination and Attitudes toward COVID-19 Vaccination for Their Children
2.3.5. Interpersonal Level Factors: Influence of Social Media
2.4. Sample Size Planning
2.5. Statistical Analyses
3. Results
3.1. Background Characteristics of the Participants
3.2. Changes in Parental Acceptability and Attitudes toward Children’s COVID-19 Vaccination
3.3. Factors Associated with Parental Acceptability of COVID-19 Vaccination
4. Discussion
5. Conclusions
Supplementary Materials
Author Contributions
Funding
Institutional Review Board Statement
Informed Consent Statement
Data Availability Statement
Acknowledgments
Conflicts of Interest
Appendix A. Associations between Individual Items of the Positive/Negative Attitude Scale and Parental Acceptability
Round 1 (n = 208) | Round 2 (n = 229) | |||||||
---|---|---|---|---|---|---|---|---|
OR (95%CI) | p Values | AOR (95%CI) | p Values | OR (95%CI) | p Values | AOR (95%CI) | p Values | |
Positive Attitudes Scale | ||||||||
COVID-19 vaccination is highly effective in protecting your child from COVID-19 | 6.75 (3.54, 12.86) | <0.001 | 6.72 (3.48, 12.96) | <0.001 | 7.68 (3.81, 15.50) | <0.001 | 8.14 (3.98, 16.66) | <0.001 |
Taking up COVID-19 vaccination can contribute to the control of COVID-19 in China | 2.27 (1.02, 5.09) | 0.04 | 2.08 (0.92, 4.75) | 0.08 | 2.81 (0.95, 8.35) | 0.06 | 2.91 (0.97, 8.72) | 0.06 |
China will have an adequate supply of COVID-19 vaccine | 1.90 (0.98, 3.70) | 0.06 | 2.07 (1.03, 4.14) | 0.04 | 1.59 (0.62, 4.08) | 0.33 | 1.66 (0.64, 4.29) | 0.30 |
Negative Attitudes Scale | ||||||||
Your child will have severe side effects after receiving COVID-19 vaccination | 0.99 (0.42, 2.34) | 0.99 | 1.02 (0.42, 2.45) | 0.97 | 0.64 (0.28, 1.49) | 0.30 | 0.61 (0.26, 1.44) | 0.26 |
The protection of COVID-19 vaccines will only last for a short time | 1.29 (0.63, 2.65) | 0.49 | 1.39 (0.66, 2.92) | 0.38 | 0.76 (0.40, 1.44) | 0.40 | 0.76 (0.40, 1.46) | 0.41 |
Your child is afraid of vaccination | 0.91 (0.47, 1.80) | 0.80 | 0.97 (0.49, 1.95) | 0.94 | 1.43 (0.64, 3.18) | 0.38 | 1.45 (0.65, 3.25) | 0.36 |
You do not have time to take your child for COVID-19 vaccination | 1.67 (0.71, 3.93) | 0.24 | 1.79 (0.75, 4.29) | 0.19 | 1.80 (0.78, 4.11) | 0.17 | 1.79 (0.78, 4.11) | 0.17 |
References
- Barchielli, B.; Cricenti, C.; Gallè, F.; Sabella, E.A.; Liguori, F.; Da Molin, G.; Liguori, G.; Orsi, G.B.; Giannini, A.M.; Ferracuti, S.; et al. Climate Changes, Natural Resources Depletion, COVID-19 Pandemic, and Russian-Ukrainian War: What Is the Impact on Habits Change and Mental Health? Int. J. Environ. Res. Public Health 2022, 19, 11929. [Google Scholar] [CrossRef] [PubMed]
- World Health Organization (WHO). Coronavirus COVID-19 Dashboard. Available online: https://covid19.who.int (accessed on 8 December 2022).
- Mueller, A.L.; McNamara, M.; Sinclair, D. Why does COVID-19 disproportionately affect older people? Aging 2020, 12, 9959–9981. [Google Scholar] [CrossRef]
- Cui, X.; Zhao, Z.; Zhang, T.; Guo, W.; Guo, W.; Zheng, J.; Zhang, J.; Dong, C.; Na, R.; Zheng, L.; et al. A systematic review and meta-analysis of children with coronavirus disease 2019 (COVID-19). J. Med. Virol. 2020, 93, 1057–1069. [Google Scholar] [CrossRef] [PubMed]
- Clarke, K.; Kim, Y.; Jones, J.; Lee, A.; Deng, Y.; Nycz, E.; Hall, A.J. Pediatric Infection-Induced SARS-CoV-2 Seroprevalence Estimation Using Commercial Laboratory Specimens: How Representative Is It of the General U.S. Pediatric Population? 2022. Available online: https://ssrn.com/abstract=4092074 (accessed on 27 November 2022).
- Centers for Disease Control and Prevention: COVID Data Tracker—Wastewater Suveillance (2021). Available online: https://covid.cdc.gov/covid-data-tracker/#wastewdatatracker-home (accessed on 11 April 2022).
- Statista. Number of Coronavirus (COVID-19) Cases in Germany in 2022, by Age Group and Gender. 2022. Available online: https://www.statista.com/statistics/1105465/coronavirus-covid-19-cases-age-group-germany/ (accessed on 28 November 2022).
- GOV.UK. Coronavirus (COVID-19) in the UK. 2022. Available online: https://coronavirus.data.gov.uk/details/cases?areaType=nation&areaName=England (accessed on 28 November 2022).
- Marks, K.J.; Whitaker, M.; Agathis, N.T.; Anglin, O.; Milucky, J.; Patel, K.; Pham, H.; Kirley, P.D.; Kawasaki, B.; Meek, J.; et al. Hospitalization of Infants and Children Aged 0–4 Years with Laboratory-Confirmed COVID-19—COVID-NET, 14 States, March 2020–February 2022. MMWR Morb. Mortal Wkly. Rep. 2022, 71, 429–436. [Google Scholar] [CrossRef] [PubMed]
- COVID-19 Epidemiology in Children Ages 6 Months–4 Years. 2022. Available online: https://www.cdc.gov/vaccines/acip/meetings/downloads/slides-2022-06-17-18/02-covid-fleming-dutra-508.pdf (accessed on 29 November 2022).
- Gonzalez-Dambrauskas, S.; Vasquez-Hoyos, P.; Camporesi, A.; Cantillano, E.M.; Dallefeld, S.; Dominguez-Rojas, J.; Francoeur, C.; Gurbanov, A.; Mazzillo-Vega, L.; Shein, S.L.; et al. Paediatric critical COVID-19 and mortality in a multinational prospective cohort. Lancet Reg. Health Am. 2022, 12, 100272. [Google Scholar] [CrossRef]
- Tregoning, J.S.; Flight, K.E.; Higham, S.L.; Wang, Z.; Pierce, B.F. Progress of the COVID-19 vaccine effort: Viruses, vaccines and variants versus efficacy, effectiveness and escape. Nat. Rev. Immunol. 2021, 21, 626–636. [Google Scholar] [CrossRef]
- Bolcato, M.; Rodriguez, D.; Feola, A.; Di Mizio, G.; Bonsignore, A.; Ciliberti, R.; Tettamanti, C.; Aurilio, M.T.; Aprile, A. COVID-19 Pandemic and Equal Access to Vaccines. Vaccines 2021, 9, 538. [Google Scholar] [CrossRef]
- Aurilio, M.T.; Mennini, F.; Gazzillo, S.; Massini, L.; Bolcato, M.; Feola, A.; Ferrari, C.; Coppeta, L. Intention to Be Vaccinated for COVID-19 among Italian Nurses during the Pandemic. Vaccines 2021, 9, 500. [Google Scholar] [CrossRef]
- Fox, J.; White, P.J.; Macdonald, N.; Weber, J.; McClure, M.; Fidler, S.; Ward, H. Reductions in HIV transmission risk behaviour following diagnosis of primary HIV infection: A cohort of high-risk men who have sex with men. HIV Med. 2009, 10, 432–438. [Google Scholar] [CrossRef]
- Colfax, G.N.; Buchbinder, S.P.; Cornelisse, P.G.A.; Vittinghoff, E.; Mayer, K.; Celum, C. Sexual risk behaviors and implications for secondary HIV transmission during and after HIV seroconversion. Aids 2002, 16, 1529–1535. [Google Scholar] [CrossRef]
- Hause, A.M.; Marquez, P.; Zhang, B.; Myers, T.R.; Gee, J.; Su, J.R.; Parker, C.; Thompson, D.; Panchanathan, S.S.; Shimabukuro, T.T.; et al. COVID-19 mRNA Vaccine Safety Among Children Aged 6 Months–5 Years—United States, 18 June 2022–21 August 2022. MMWR Morb. Mortal Wkly. Rep. 2022, 71, 1115–1120. [Google Scholar] [CrossRef] [PubMed]
- Ghanem, A.; Little, S.J.; Drumright, L.; Liu, L.; Morris, S.; Garfein, R.S. High-Risk Behaviors Associated with Injection Drug Use Among Recently HIV-Infected Men Who Have Sex with Men in San Diego, CA. AIDS Behav. 2011, 15, 1561–1569. [Google Scholar] [CrossRef]
- Food and Drug Administration. Pfizer-BioNTech COVID-19 Vaccine EUA Letter of Authorization Reissued 8 July 2022; US Department of Health and Human Services, Food and Drug Administration: Silver Spring, MD, USA, 2022; Available online: https://www.fda.gov/media/150386/download (accessed on 27 November 2022).
- Summary of Data Publicly Reported by the Centers for Disease Control and Prevention. 2022. Available online: https://www.aap.org/en/pages/2019-novel-coronavirus-covid-19-infections/children-and-covid-19-vaccination-trends/ (accessed on 27 November 2022).
- Australian Government. ATAGI recommend the COVID-19 Vaccination for Some Children Aged 6 Months to under 5 Years. Available online: https://www.health.gov.au/news/atagi-recommend-the-covid-19-vaccination-for-some-children-aged-6-months-to-under-5-years (accessed on 3 January 2023).
- National Advisory Committee on Immunization (NACI). Recommendations on the Use of Moderna Spikevax COVID-19 Vaccine in Children 6 Months to 5 Years of Age. Available online: https://www.canada.ca/content/dam/phac-aspc/documents/services/immunization/national-advisory-committee-on-immunization-naci/recommendations-use-moderna-spikevax-covid-19-vaccine-children-6-months-5-years.pdf (accessed on 3 January 2023).
- The Government of the Hong Kong SAR. COVID-19 Vaccination of Children Aged under 3 Begins Today. Available online: https://www.info.gov.hk/gia/general/202208/04/P2022080400470.htm (accessed on 3 January 2023).
- Shenzhen Municipal Health Commission. Frequent Answers and Questions about the Implementation of COVID-19 Vaccines for Children Aged 3–11 Years Old in 2021. Available online: http://wjw.sz.gov.cn/yqxx/content/post_9299120.html (accessed on 1 August 2022).
- She, J.; Liu, L.; Liu, W. Providing children with COVID-19 vaccinations is challenging due to lack of data and wide-ranging parental acceptance. Acta Paediatr. 2021, 111, 35–44. [Google Scholar] [CrossRef] [PubMed]
- Mangat, C.; Rich, J.; Sanghavi, D.; Schmidt, R.; Milosavljevic, N.; Linh, T.; Bansal, P. Parents’ perspective on COVID-19 vaccine in children 6 months through 4 years: A cross-sectional study from Northwest Wisconsin. BMJ Open 2022, 12, e065453. [Google Scholar] [CrossRef]
- Bell, S.; Clarke, R.; Mounier-Jack, S.; Walker, J.L.; Paterson, P. Parents’ and guardians’ views on the acceptability of a future COVID-19 vaccine: A multi-methods study in England. Vaccine 2020, 38, 7789–7798. [Google Scholar] [CrossRef]
- Wang, Q.; Xiu, S.; Zhao, S.; Wang, J.; Han, Y.; Dong, S.; Huang, J.; Cui, T.; Yang, L.; Shi, N.; et al. Vaccine Hesitancy: COVID-19 and Influenza Vaccine Willingness among Parents in Wuxi, China—A Cross-Sectional Study. Vaccines 2021, 9, 342. [Google Scholar] [CrossRef] [PubMed]
- Wang, Z.; She, R.; Chen, X.; Li, L.; Li, L.; Huang, Z.; Lau, J.T.F. Parental acceptability of COVID-19 vaccination for children under the age of 18 years among Chinese doctors and nurses: A cross-sectional online survey. Hum. Vaccines Immunother. 2021, 17, 3322–3332. [Google Scholar] [CrossRef]
- Xu, Y.; Zhang, R.; Zhou, Z.; Fan, J.; Liang, J.; Cai, L.; Peng, L.; Ren, F.; Lin, W. Parental psychological distress and attitudes towards COVID-19 vaccination: A cross-sectional survey in Shenzhen, China. J. Affect. Disord. 2021, 292, 552–558. [Google Scholar] [CrossRef]
- Feng, H.; Zhu, H.; Zhang, H.; Cao, L.; Li, L.; Wang, J.; Huang, Y.; Lai, X.; Lyu, Y.; Jing, R.; et al. Caregivers’ intentions to COVID-19 vaccination for their children in China: A cross-sectional survey. Hum. Vaccines Immunother. 2021, 17, 4799–4805. [Google Scholar] [CrossRef]
- Du, M.; Tao, L.; Liu, J. The Association Between Risk Perception and COVID-19 Vaccine Hesitancy for Children Among Reproductive Women in China: An Online Survey. Front. Med. 2021, 8, 1494. [Google Scholar] [CrossRef]
- Wan, X.; Huang, H.; Shang, J.; Xie, Z.; Jia, R.; Lu, G.; Chen, C. Willingness and influential factors of parents of 3-6-year-old children to vaccinate their children with the COVID-19 vaccine in China. Hum. Vaccines Immunother. 2021, 17, 3969–3974. [Google Scholar] [CrossRef] [PubMed]
- Wu, L.; Huang, Z.; Guo, X.; Liu, J.; Sun, X. Measuring parents’ acceptance of non-national immunization program vaccines for children and its influencing factors during the COVID-19 pandemic in Shanghai, China. Hum. Vaccines Immunother. 2022, 18, 2069427. [Google Scholar] [CrossRef] [PubMed]
- Zhang, M.X.; Lin, X.Q.; Chen, Y.; Tung, T.H.; Zhu, J.S. Determinants of parental hesitancy to vaccinate their children against COVID-19 in China. Expert Rev. Vaccines 2021, 20, 1339–1349. [Google Scholar] [CrossRef] [PubMed]
- Xu, Y.; Xu, D.; Luo, L.; Ma, F.; Wang, P.; Li, H.; Li, Q.; Wei, L.; Diao, J.; Liu, Y.; et al. A Cross-Sectional Survey on COVID-19 Vaccine Hesitancy Among Parents from Shandong vs. Zhejiang. Front. Public Health 2021, 9, 1722. [Google Scholar] [CrossRef]
- Wu, J.; Zhao, L.; Wang, M.; Gu, J.; Wei, W.; Li, Q.; Ma, M.; Mu, Z.; Miao, Y. Guardians’ willingness to vaccinate their teenagers against COVID-19 in China: A national cross-sectional survey. J. Affect. Disord. 2021, 299, 196–204. [Google Scholar] [CrossRef]
- Ma, L.; Yang, J.; Zhang, T.; Han, X.; Huang, Q.; Yang, Y.; Feng, L.; Yang, W.; Wang, C. Willingness toward COVID-19 vaccination, coadministration with other vaccines and receive a COVID-19 vaccine booster: A cross-sectional study on the guardians of children in China. Hum. Vaccines Immunother. 2022, 18, 2049169. [Google Scholar] [CrossRef]
- Li, T.; Qiu, X.; Gong, X.; Zhan, R.; Zheng, X. The cross-sectional survey on COVID-19 vaccine hesitancy and it predictors among Chinese parents of 3–17 years aged children in Shenzhen City. Ann. Agric. Environ. Med. 2022, 29, 120–125. [Google Scholar] [CrossRef]
- Qin, C.; Wang, R.; Tao, L.; Liu, M.; Liu, J. Association Between Risk Perception and Acceptance for a Booster Dose of COVID-19 Vaccine to Children Among Child Caregivers in China. Front. Public Health 2022, 10, 834572. [Google Scholar] [CrossRef]
- Zhou, X.; Wang, S.; Zhang, K.; Chen, S.; Chan, P.S.; Fang, Y.; Cao, H.; Chen, H.; Hu, T.; Chen, Y.; et al. Changes in Parents’ COVID-19 Vaccine Hesitancy for Children Aged 3–17 Years before and after the Rollout of the National Childhood COVID-19 Vaccination Program in China: Repeated Cross-Sectional Surveys. Vaccines 2022, 10, 1478. [Google Scholar] [CrossRef]
- Valente, T.W.; Fosados, R. Diffusion of Innovations and Network Segmentation: The Part Played by People in Promoting Health. Sex. Transm. Dis. 2006, 33, S23–S31. [Google Scholar] [CrossRef]
- Zhang, K.; Fang, Y.; Chan, P.S.-F.; Cao, H.; Chen, H.; Hu, T.; Chen, Y.; Zhou, X.; Wang, Z. Behavioral Intention to Get a Booster Dose of COVID-19 Vaccine among Chinese Factory Workers. Int. J. Environ. Res. Public Health 2022, 19, 5245. [Google Scholar] [CrossRef] [PubMed]
- Zhang, K.C.; Fang, Y.; Cao, H.; Chen, H.; Hu, T.; Chen, Y.; Zhou, X.; Wang, Z. Behavioral Intention to Receive a COVID-19 Vaccination Among Chinese Factory Workers: Cross-sectional Online Survey. J. Med. Internet Res. 2021, 23, e24673. [Google Scholar] [CrossRef] [PubMed]
- District, L. Commerce Bureau of Shenzhen Municipality. 2022. Available online: http://commerce.sz.gov.cn/tzly/qyfb/gqcyjs/content/post_8571905.html (accessed on 25 November 2022).
- Pan, Y.; Fang, Y.; Xin, M.; Dong, W.; Zhou, L.; Hou, Q.; Li, F.; Sun, G.; Zheng, Z.; Yuan, J.; et al. Self-Reported Compliance with Personal Preventive Measures Among Chinese Factory Workers at the Beginning of Work Resumption Following the COVID-19 Outbreak: Cross-Sectional Survey Study. J. Med. Internet Res. 2020, 22, e22457. [Google Scholar] [CrossRef] [PubMed]
- Yuan, J.; Cao, B.; Zhang, C.; Chan, P.S.F.; Xin, M.; Fang, Y.; Chen, Y.; Huang, D.; Li, L.; Xuan, X.; et al. Changes in Compliance with Personal Preventive Measures and Mental Health Status Among Chinese Factory Workers during the COVID-19 Pandemic: An Observational Prospective Cohort Study. Front. Public Health 2022, 10, 831456. [Google Scholar] [CrossRef] [PubMed]
- Pan, Y.; Xin, M.; Zhang, C.; Dong, W.; Fang, Y.; Wu, W.; Li, M.; Pang, J.; Zheng, Z.; Wang, Z.; et al. Associations of Mental Health and Personal Preventive Measure Compliance with Exposure to COVID-19 Information during Work Resumption Following the COVID-19 Outbreak in China: Cross-Sectional Survey Study. J. Med. Internet Res. 2020, 22, e22596. [Google Scholar] [CrossRef] [PubMed]
- Zhang, K.C.; Fang, Y.; Cao, H.; Chen, H.; Hu, T.; Chen, Y.Q.; Zhou, X.; Wang, Z. Parental acceptability of COVID-19 vaccination for children under the age of 18 years in China: Cross-sectional online survey. JMIR Pediatr. Parent. 2020, 3, e24827. [Google Scholar] [CrossRef]
- Wang, Z.; Wang, J.; Fang, Y.; Gross, D.L.; Wong, M.C.; Wong, E.L.; Lau, J.T. Parental acceptability of HPV vaccination for boys and girls aged 9–13 years in China—A population-based study. Vaccine 2018, 36, 2657–2665. [Google Scholar] [CrossRef]
- Coronavirus (COVID-19) Vaccinations. 2022. Available online: https://news.google.com/covid19/map?hl=zhCN&mid=%2Fm%2F0fbp0&gl=CN&ceid=CN%3Azh-Hans&state=4 (accessed on 3 December 2022).
- China Approves COVID-19 Vaccines for Children above 3 Years Old. Available online: https://www.globaltimes.cn/page/202106/1225639.shtml (accessed on 9 December 2022).
- Net, X. Over 84 Million Chinese Children Vaccinated against COVID-19. Available online: http://www.news.cn/english/2021-11/13/c_1310309137.htm (accessed on 10 December 2022).
- Katz, S.E.; Edwards, K. Protecting Children Against Omicron. JAMA 2022, 327, 2195–2197. [Google Scholar] [CrossRef]
- Buonsenso, D.; Valentini, P.; Macchi, M.; Folino, F.; Pensabene, C.; Patria, M.F.; Agostoni, C.; Castaldi, S.; Lecce, M.; Giannì, M.L.; et al. Caregivers’ Attitudes Toward COVID-19 Vaccination in Children and Adolescents with a History of SARS-CoV-2 Infection. Front. Pediatr. 2022, 10, 867968. [Google Scholar] [CrossRef]
Round 1 (n = 208) | Round 2 (n = 229) | p Values | |
---|---|---|---|
n (%) | n (%) | ||
Sociodemographic characteristics | |||
Age of the parent, years | |||
18–30 | 106 (51.0) | 80 (34.9) | |
31–40 | 97 (46.6) | 124 (54.1) | |
>40 | 5 (2.4) | 25 (10.9) | <0.001 |
Sex | |||
Male | 89 (42.8) | 98 (42.8) | |
Female | 119 (57.2) | 131 (57.2) | 1.00 |
Relationship status | |||
Married | 203 (97.6) | 224 (97.8) | |
Single or divorced | 3 (1.4) | 5 (2.2) | |
Having a stable partner | 2 (1.0) | 0 (0.0) | 0.28 |
Education | |||
Senior high or below | 127 (61.1) | 113 (49.3) | |
College and above | 81 (38.9) | 116 (50.7) | 0.02 |
Monthly personal income, RMB (USD) | |||
<3000 (462) | 49 (23.6) | 35 (15.3) | |
3000–6999 (462–1077) | 112 (53.8) | 139 (60.7) | |
≥7000 (1078) | 47 (22.6) | 55 (24.0) | 0.09 |
Type of work | |||
Frontline workers | 132 (63.5) | 160 (69.9) | |
Management staff | 76 (36.5) | 69 (30.1) | 0.19 |
Age of the child, months | |||
24–35 | 112 (53.8) | 119 (52.0) | |
12–23 | 91 (43.8) | 95 (41.5) | |
6–11 | 5 (2.4) | 15 (6.6) | 0.12 |
Personal COVID-19 preventive measures in the past month | |||
Frequency of face mask wearing in public spaces or on transportation other than the workplace | |||
Every time | 155 (74.5) | 179 (78.2) | |
Often | 34 (16.3) | 44 (19.2) | |
Sometimes | 16 (7.7) | 5 (2.2) | |
Never | 3 (1.4) | 1 (0.4) | 0.03 |
Frequency of face mask wearing when you have close contact with other people in the workplace | |||
Every time | 133 (63.9) | 167 (72.9) | |
Often | 45 (21.6) | 49 (21.4) | |
Sometimes | 25 (12.0) | 11 (4.8) | |
Never | 5 (2.4) | 2 (0.9) | 0.02 |
Frequency of sanitizing of hands, using soaps, liquid soaps, or alcohol-based sanitizer, after returning from public spaces or touching public installations | |||
Every time | 110 (52.9) | 109 (47.6) | |
Often | 53 (25.5) | 69 (30.1) | |
Sometimes | 41 (19.7) | 44 (19.2) | |
Never | 4 (1.9) | 7 (3.1) | 0.57 |
Self-reported avoiding of social and meal gathering with other people who do not live together | |||
No | 82 (39.4) | 93 (40.6) | |
Yes | 126 (60.6) | 136 (59.4) | 0.88 |
Self-reported avoiding of crowded places | |||
No | 72 (34.6) | 81 (35.4) | |
Yes | 136 (65.4) | 148 (64.6) | 0.95 |
Round 1 (n = 208) | Round 2 (n = 229) | Unadjusted p Values | Adjusted p Values a | Effect Size | |
---|---|---|---|---|---|
n (%) | n (%) | ||||
Parental acceptability of COVID-19 vaccination for their child aged 6–35 months | |||||
Likelihood of having the child take up COVID-19 vaccination | |||||
Very unlikely/unlikely/neutral | 69 (33.2) | 47 (20.5) | |||
Likely/very likely | 139 (66.8) | 182 (79.5) | 0.004 | 0.01 | 0.29 |
Parental hesitancy to receive COVID-19 vaccination | |||||
No | 171 (82.2) | 228 (99.6) | |||
Yes | 37 (17.8) | 1 (0.4) | <0.001 | <0.001 | 0.74 |
Attitudes toward COVID-19 vaccination for their children | |||||
Positive attitudes toward COVID-19 vaccination, n (%) agree | |||||
COVID-19 vaccination is highly effective in protecting your child from COVID-19 | 119 (57.2) | 165 (72.1) | 0.002 | 0.02 | 0.31 |
Taking up COVID-19 vaccination can contribute to the control of COVID-19 in China | 180 (86.5) | 214 (93.4) | 0.02 | 0.01 | 0.23 |
China will have an adequate supply of COVID-19 vaccine | 161 (77.4) | 204 (89.1) | 0.002 | 0.001 | 0.32 |
Positive Attitude Scale score, mean (SD) | 8.1 (1.1) | 8.5 (0.9) | <0.001 | 0.002 | 0.34 |
Negative attitudes toward COVID-19 vaccination, n (%) agree | |||||
Your child will have severe side effects after receiving COVID-19 vaccination | 27 (13.0) | 33 (14.4) | 0.77 | 0.89 | 0.04 |
The protection of COVID-19 vaccines will only last for a short time | 45 (21.6) | 114 (49.8) | <0.001 | <0.001 | 0.60 |
Your child is afraid of vaccination | 49 (23.6) | 55 (24.0) | 1.00 | 0.62 | 0.009 |
You do not have time to take your child for COVID-19 vaccination | 33 (15.9) | 57 (24.9) | 0.03 | 0.04 | 0.22 |
Negative Attitude Scale score, mean (SD) | 7.6 (1.6) | 7.9 (1.9) | 0.06 | 0.03 | 0.18 |
Perceived subjective norm related to child’s COVID-19 vaccination: your family member would support you in having the child take up COVID-19 vaccination | |||||
Agree, n (%) | 105 (50.5) | 156 (68.1) | <0.001 | <0.001 | 0.36 |
Response score, mean (SD) | 2.4 (0.6) | 2.6 (0.6) | <0.001 | 0.004 | 0.33 |
Perceived behavioural control to have the child take up COVID-19 vaccination: having the child receive COVID-19 vaccination is easy for you if you want them to | |||||
Agree, n (%) | 99 (47.6) | 143 (62.4) | 0.003 | 0.02 | 0.30 |
Response score, mean (SD) | 2.4 (0.6) | 2.6 (0.6) | 0.002 | 0.01 | 0.29 |
Frequency of exposing to the following information on social media (e.g., WeChat, WeChat moments, Weibo, Tiktok) in the past month | |||||
Testimonials given by recipients of COVID-19 vaccination on social media | |||||
Almost none | 100 (48.1) | 53 (23.1) | |||
Seldom | 55 (26.4) | 72 (31.4) | |||
Sometimes | 33 (15.9) | 69 (30.1) | |||
Always | 20 (9.6) | 35 (15.3) | <0.001 | <0.001 | 0.34 |
Response score, mean (SD) | 1.9 (1.0) | 2.4 (1.0) | <0.001 | <0.001 | 0.50 |
COVID-19 pandemic is not under control in some countries after scaling up COVID-19 vaccination | |||||
Almost none | N.A. | 39 (17.0) | |||
Seldom | N.A. | 79 (34.5) | |||
Sometimes | N.A. | 66 (28.8) | |||
Always | N.A. | 45 (19.7) | |||
Response score, mean (SD) | N.A. | 2.5 (1.0) | N.A. | N.A. | N.A. |
Infectiousness and harms of the variants concern of COVID-19 | |||||
Almost none | N.A. | 26 (11.4) | |||
Seldom | N.A. | 53 (23.1) | |||
Sometimes | N.A. | 88 (38.4) | |||
Always | N.A. | 62 (27.1) | |||
Response score, mean (SD) | N.A. | 2.8 (1.0) | N.A. | N.A. | N.A. |
Outbreak caused by variants concern of COVID-19 in some places of China | |||||
Almost none | N.A. | 34 (14.8) | |||
Seldom | N.A. | 71 (31.0) | |||
Sometimes | N.A. | 82 (35.8) | |||
Always | N.A. | 42 (18.3) | |||
Response score, mean (SD) | N.A. | 2.6 (1.0) | N.A. | N.A. | N.A. |
People contract COVID-19 after receiving primary series of COVID-19 | |||||
Almost none | N.A. | 50 (21.8) | |||
Seldom | N.A. | 93 (40.6) | |||
Sometimes | N.A. | 71 (31.0) | |||
Always | N.A. | 15 (6.6) | |||
Response score, mean (SD) | N.A. | 2.2 (0.9) | N.A. | N.A. | N.A. |
Round 1 (n = 208) | Round 2 (n = 229) | |||
---|---|---|---|---|
OR (95%CI) | p Values | OR (95%CI) | p Values | |
Sociodemographic characteristics | ||||
Age group, years | ||||
18–30 | 1.0 | 1.0 | ||
31–40 | 1.57 (0.87, 2.84) | 0.14 | 0.88 (0.45, 1.74) | 0.72 |
>40 | 0.91 (0.15, 5.68) | 0.92 | 6.48 (0.82, 51.37) | 0.08 |
Sex | ||||
Male | 1.0 | 1.0 | ||
Female | 1.14 (0.64, 2.04) | 0.66 | 2.64 (1.36, 5.11) | 0.004 |
Relationship status | ||||
Married | 1.0 | 1.0 | ||
Single or divorced | N.A. | N.A. | 1.03 (0.11, 9.47) | 0.98 |
Having a stable partner | 0.50 (0.03, 8.18) | 0.63 | N.A. | N.A. |
Education | ||||
Senior high or below | 1.0 | 1.0 | ||
College and above | 0.90 (0.50, 1.63) | 0.73 | 0.36 (0.18, 0.71) | 0.003 |
Monthly personal income, RMB (USD) | ||||
<3000 (462) | 1.0 | 1.0 | ||
3000–6999 (462–1077) | 1.17 (0.57, 2.38) | 0.67 | 0.54 (0.17, 1.65) | 0.28 |
≥7000 (1078) | 0.94 (0.41, 2.16) | 0.88 | 0.32 (0.10, 1.04) | 0.06 |
Type of work | ||||
Frontline workers | 1.0 | 1.0 | ||
Management staff | 0.77 (0.43, 1.40) | 0.39 | 0.63 (0.32, 1.23) | 0.17 |
Age of the child, months | ||||
24–35 | 1.0 | 1.0 | ||
12–23 | 1.00 (0.56, 1.81) | 0.99 | 1.00 (0.62, 1.93) | 0.99 |
6–11 | 0.74 (0.12, 4.62) | 0.75 | 1.73 (0.37, 8.18) | 0.49 |
Personal COVID-19 preventive measures in the past month | ||||
Frequency of face mask wearing in public spaces or on transportation other than the workplace | ||||
Never/sometimes/often | 1.0 | 1.0 | ||
Every time | 1.82 (0.96, 3.46) | 0.07 | 1.50 (0.72, 3.12) | 0.28 |
Frequency of face mask wearing when you have close contact with other people in the workplace | ||||
Never/sometimes/often | 1.0 | 1.0 | ||
Every time | 1.01 (0.56, 1.84) | 0.97 | 3.12 (1.60, 6.12) | 0.001 |
Frequency of sanitizing of hands, using soaps, liquid soaps, or alcohol-based sanitizer, after returning from public spaces or touching public installations | ||||
Never/sometimes/often | 1.0 | 1.0 | ||
Every time | 1.04 (0.59, 1.86) | 0.89 | 2.92 (1.45, 5.89) | 0.003 |
Self-reported avoiding of social and meal gathering with other people who do not live together | ||||
No | 1.0 | 1.0 | ||
Yes | 2.21 (1.22, 3.98) | 0.01 | 0.99 (0.52, 1.90) | 0.98 |
Self-reported avoiding of crowed places | ||||
No | 1.0 | 1.0 | ||
Yes | 2.14 (1.18, 3.90) | 0.01 | 0.82 (0.42, 1.63) | 0.58 |
Round 1 (n = 208) | Round 2 (n = 229) | |||||||
---|---|---|---|---|---|---|---|---|
OR (95%CI) | p Values | AOR (95%CI) | p Values | OR (95%CI) | p Values | AOR (95%CI) | p Values | |
Parental hesitancy to receive COVID-19 vaccination | ||||||||
No | 1.0 | 1.0 | ||||||
Yes | 0.26 (0.18, 0.38) | <0.001 | 0.25 (0.12, 0.54) | <0.001 | N.A. | N.A.. | N.A. | N.A. |
Attitudes toward COVID-19 vaccination for their children | ||||||||
Positive Attitude Scale | 1.88 (1.41, 2.50) | <0.001 | 1.86 (1.38, 2.50) | <0.001 | 2.04 (1.47, 2.85) | <0.001 | 1.99 (1.40, 2.85) | <0.001 |
Negative Attitude Scale | 0.96 (0.80, 1.14) | 0.61 | 0.96 (0.80, 1.16) | 0.69 | 0.86 (0.72, 1.01) | 0.07 | 0.80 (0.66, 0.97) | 0.02 |
Perceived subjective norm | 4.68 (2.66, 8.23) | <0.001 | 4.69 (2.64, 8.32) | <0.001 | 8.07 (4.20, 15.48) | <0.001 | 8.33 (4.12, 16.83) | <0.001 |
Perceived behavioural control | 1.91 (1.21, 2.99) | 0.005 | 2.02 (1.27, 3.21) | 0.003 | 2.90 (1.73, 4.87) | <0.001 | 3.09 (1.76, 5.43) | <0.001 |
Frequency of exposing to the following information on social media (e.g., WeChat, WeChat moments, Weibo, Tiktok) in the past month | ||||||||
Testimonials given by recipients of COVID-19 vaccination on social media | 1.22 (0.91, 1.65) | 0.19 | 1.24 (0.91, 1.68) | 0.18 | 0.96 (0.70, 1.33) | 0.83 | 0.79 (0.55, 1.13) | 0.20 |
COVID-19 pandemic is not under control in some countries after scaling up COVID-19 vaccination | N.A. | N.A. | N.A. | N.A. | 0.85 (0.61, 1.18) | 0.32 | 0.82 (0.57, 1.17) | 0.27 |
Infectiousness and harms of the variants concern of COVID-19 | N.A. | N.A. | N.A. | N.A. | 0.87 (0.62, 1.22) | 0.41 | 0.78 (0.53, 1.14) | 0.20 |
Outbreak caused by variants concern of COVID-19 in some places of China | N.A. | N.A. | N.A. | N.A. | 0.77 (0.54, 1.08) | 0.13 | 0.80 (0.55, 1.17) | 0.25 |
People contract COVID-19 after receiving primary series of COVID-19 | N.A. | N.A. | N.A. | N.A. | 0.88 (0.61, 1.28) | 0.50 | 0.92 (0.62, 1.38) | 0.69 |
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2023 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Zhang, K.; Liang, X.; Tam, K.L.W.; Kawuki, J.; Chan, P.S.-f.; Chen, S.; Fang, Y.; Cao, H.; Zhou, X.; Chen, Y.; et al. Changes in COVID-19 Vaccine Acceptability among Parents with Children Aged 6–35 Months in China—Repeated Cross-Sectional Surveys in 2020 and 2021. Vaccines 2023, 11, 170. https://doi.org/10.3390/vaccines11010170
Zhang K, Liang X, Tam KLW, Kawuki J, Chan PS-f, Chen S, Fang Y, Cao H, Zhou X, Chen Y, et al. Changes in COVID-19 Vaccine Acceptability among Parents with Children Aged 6–35 Months in China—Repeated Cross-Sectional Surveys in 2020 and 2021. Vaccines. 2023; 11(1):170. https://doi.org/10.3390/vaccines11010170
Chicago/Turabian StyleZhang, Kechun, Xue Liang, Karen Lau Wa Tam, Joseph Kawuki, Paul Shing-fong Chan, Siyu Chen, Yuan Fang, He Cao, Xiaofeng Zhou, Yaqi Chen, and et al. 2023. "Changes in COVID-19 Vaccine Acceptability among Parents with Children Aged 6–35 Months in China—Repeated Cross-Sectional Surveys in 2020 and 2021" Vaccines 11, no. 1: 170. https://doi.org/10.3390/vaccines11010170
APA StyleZhang, K., Liang, X., Tam, K. L. W., Kawuki, J., Chan, P. S. -f., Chen, S., Fang, Y., Cao, H., Zhou, X., Chen, Y., Hu, T., Chen, H., & Wang, Z. (2023). Changes in COVID-19 Vaccine Acceptability among Parents with Children Aged 6–35 Months in China—Repeated Cross-Sectional Surveys in 2020 and 2021. Vaccines, 11(1), 170. https://doi.org/10.3390/vaccines11010170